Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Prevention of enteric fever in travellers with typhoid conjugate vaccines.

Britto C., Jin C., Theiss-Nyland K., Pollard AJ.

The 2018 WHO position paper on typhoid vaccines indicates preference for the use of new generation typhoid conjugate vaccines over existing parenteral Vi-polysaccharide (Vi-PS) and oral attenuated Ty21a vaccines

More information Original publication

DOI

10.1093/jtm/tay120

Type

Journal article

Publication Date

2018-01-01T00:00:00+00:00

Volume

Keywords

Humans, Mass Vaccination, Travel, Typhoid Fever, Typhoid-Paratyphoid Vaccines, Vaccines, Conjugate